verified SJR 1,195 · Q1 • database Scopus / SJR & Web of Science indexed

United Kingdom · Informa Healthcare

workspace_premium Q1 — Drug Discovery lock Subscription

Expert Opinion on Drug Discovery

Expert Opinion on Drug Discovery is a journal indexed in SJR in Drug Discovery with an H index of 90. It has an SJR impact factor of 1,195 and it has a best quartile of Q1. It has an SJR impact factor of 1,195.

Expert Opinion on Drug Discovery focuses its scope in these topics and keywords: drug, discovery, preclinical, delivered, schizophrenia, tool, drugs, prion, target, bipolar, ...

ISSN: 1746-0441

Publisher: Informa Healthcare

Category: Drug Discovery

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,195 Q1

H-index 90

Acceptance rate pie_chart

28% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,195

H-index

Docs (year)

115

Docs 3y

330

Total refs

11755

Cites 3y

1843

Citable 3y

281

Cites/Doc 2y

4.67

Ref/Doc

102.22

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Approaches for discovering anti-prion compounds: lessons learned and challenges ahead

What translatable knowledge from dengue vaccine design can we pass onto future anti-parasitic vaccine development?

Design of chemical libraries for screening

Considering the economic principles of pharmaceutical R&D

Computational methods to support high-content screening: from compound selection and data analysis to postulating target hypotheses

Computational approaches in chemogenomics and chemical biology: current and future impact on drug discovery

Combining label-free cell phenotypic profiling with computational approaches for novel drug discovery

Chemical similarity searches: when is complexity justified?

Carbohydrate-based vaccine adjuvants -discovery and development

Cannabinoid 1 G protein-coupled receptor (periphero-)neutral antagonists: emerging therapeutics for treating obesity-driven metabolic disease and reducing cardiovascular risk

Canin vitroassessment provide relevant end points for cognitive drug programs?

Can pharmacoeconomics and ethics be balanced in drug research and development?

SHOW MORE ARTICLES

Axitinib: from preclinical development to future clinical perspectives in renal cell carcinoma

Advances in microwave-assisted synthesis and the impact of novel drug discovery

Anticancer drug discovery using multicellular tumor spheroid models

Animal models in tuberculosis research -where is the beef?

Animal models for ebolavirus countermeasures discovery: what defines a useful model?

Animal and cellular models for hypolipidemic drugs

An update on hybrid drugs in cardiovascular drug research

An overview of spirooxindole as a promising scaffold for novel drug discovery

An overview of molecular fingerprint similarity search in virtual screening

An overview of drug discovery efforts for eczema: why is this itch so difficult to scratch?

Advances in the molecular modeling and quantitative structure-activity relationship-based design for antihistamines

Advances in the discovery and development of trematocidal drugs

FAQs

Expert Opinion on Drug Discovery has an SJR of 1,195 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Expert Opinion on Drug Discovery is 28%.

Expert Opinion on Drug Discovery

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Expert Opinion on Drug Discovery?

What is the APC / publication cost?

What is the acceptance rate?